Alta Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-2,568
| Closed | -$812K | – | 90 |
|
|
2020
Q1 | $812K | Buy |
2,568
+1,284
| +100% | +$406K | 0.04% | 69 |
|
|
2019
Q4 | $381K | Hold |
1,284
| – | – | 0.02% | 72 |
|
|
2019
Q3 | $298K | Hold |
1,284
| – | – | 0.02% | 76 |
|
|
2019
Q2 | $300K | Hold |
1,284
| – | – | 0.02% | 79 |
|
|
2019
Q1 | $303K | Sell |
1,284
-250
| -16% | -$59K | 0.02% | 76 |
|
|
2018
Q4 | $461K | Sell |
1,534
-130
| -8% | -$39.1K | 0.03% | 66 |
|
|
2018
Q3 | $587K | Hold |
1,664
| – | – | 0.03% | 63 |
|
|
2018
Q2 | $482K | Sell |
1,664
-216
| -11% | -$62.6K | 0.03% | 61 |
|
|
2018
Q1 | $514K | Hold |
1,880
| – | – | 0.03% | 59 |
|
|
2017
Q4 | $598K | Hold |
1,880
| – | – | 0.04% | 57 |
|
|
2017
Q3 | $588K | Hold |
1,880
| – | – | 0.04% | 58 |
|
|
2017
Q2 | $510K | Buy |
1,880
+15
| +0.8% | +$4.07K | 0.03% | 61 |
|
|
2017
Q1 | $509K | Sell |
1,865
-24
| -1% | -$6.55K | 0.03% | 62 |
|
|
2016
Q4 | $535K | Hold |
1,889
| – | – | 0.04% | 65 |
|
|
2016
Q3 | $591K | Sell |
1,889
-40,635
| -96% | -$12.7M | 0.04% | 64 |
|
|
2016
Q2 | $10.3M | Buy |
42,524
+1,412
| +3% | +$341K | 0.63% | 44 |
|
|
2016
Q1 | $10.7M | Buy |
41,112
+25,317
| +160% | +$6.59M | 0.66% | 43 |
|
|
2015
Q4 | $4.84M | Buy |
15,795
+1,539
| +11% | +$471K | 0.39% | 42 |
|
|
2015
Q3 | $4.16M | Buy |
14,256
+1,242
| +10% | +$362K | 0.35% | 45 |
|
|
2015
Q2 | $5.26M | Buy |
13,014
+947
| +8% | +$382K | 0.43% | 44 |
|
|
2015
Q1 | $5.1M | Buy |
12,067
+10,466
| +654% | +$4.42M | 0.43% | 44 |
|
|
2014
Q4 | $543K | Hold |
1,601
| – | – | 0.05% | 69 |
|
|
2014
Q3 | $529K | Hold |
1,601
| – | – | 0.05% | 66 |
|
|
2014
Q2 | $504K | Buy |
1,601
+19
| +1% | +$5.98K | 0.05% | 70 |
|
|
2014
Q1 | $483K | Hold |
1,582
| – | – | 0.05% | 70 |
|
|
2013
Q4 | $442K | Hold |
1,582
| – | – | 0.05% | 66 |
|
|
2013
Q3 | $380K | Hold |
1,582
| – | – | 0.05% | 67 |
|
|
2013
Q2 | $340K | Buy |
+1,582
| New | +$340K | 0.05% | 67 |
|